Tenders/Procurement of Drugs for Cardiac Trust Fund (Annual Requirements) MHPQ/PHARM/2026-2027/Q50 OIB

Procurement of Drugs for Cardiac Trust Fund (Annual Requirements) MHPQ/PHARM/2026-2027/Q50 OIB

HEALTH

Published: Sep 11, 2026

Updated: Sep 22, 2026

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Mauritius, Africa, this opportunity is open to firms and consortiums.

Published through Mauritius e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender seeks the procurement of essential drugs for the Cardiac Trust Fund, representing the annual requirements for the period 2026-2027. The contracting authority is located in Mauritius. This procurement falls under the pharmaceutical sector and is crucial for the ongoing operations and patient care provided by the Cardiac Trust Fund. Typically, tenders of this nature require suppliers to demonstrate their capability to provide high-quality pharmaceutical products that meet stringent international and national regulatory standards, including Good Manufacturing Practices (GMP). Bidders are expected to submit comprehensive proposals detailing their product offerings, including specific drug names, dosages, and packaging. Evidence of regulatory approval, such as Certificates of Pharmaceutical Product (CPP) or equivalent documentation, will likely be a mandatory requirement. Furthermore, suppliers must be able to guarantee consistent supply chain management, timely delivery to specified locations within Mauritius, and adherence to cold chain requirements if applicable. The tender documentation will outline specific quantities required, delivery schedules, payment terms, and evaluation criteria, which will likely include factors such as price, quality, delivery reliability, and compliance with all technical specifications. Experience in supplying similar pharmaceutical products to government or trust funds may also be considered.

Data provenance

This notice is sourced from Mauritius e-Procurement and was originally published on September 11, 2026. Last refreshed today. Reference: 774631. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About HEALTH

HEALTH has issued 247 procurement notices on BidsFactory, including 38 currently open and 20 awarded contracts. Activity concentrates in Health & Medical, Governance & Public Administration, and General Supplies & Services. Tenders span 3 countries including Mauritius, Canada, and South Africa. Notices are distributed via Mauritius e-Procurement, eTenders South Africa, and SaskTenders. Most recent publication: September 17, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by HEALTH in Mauritius. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Mauritius. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Mauritius e-Procurement to access the full notice, required documents, and submission instructions. Quote reference 774631 when communicating with the contracting authority.